Position in GILD
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$370,807
-$30,996 QoQ
Shares Held
2,935
+1.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#1,540
of 2,266 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Encompass More Asset Management holds $2,871,318 across 7 Drug Manufacturers - General names. GILD ranks #3 (12.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BMY |
Bristol Myers Squibb Co
|
14,408 | $830,188 | |
| 2 | JNJ |
Johnson & Johnson
|
2,525 | $641,274 | |
| 3 | GILD |
Gilead Sciences, Inc.
This page
|
2,935 | $370,807 | |
| 4 | ABBV |
AbbVie Inc.
|
1,118 | $281,333 | |
| 5 | AZN |
Astrazeneca PLC
|
1,482 | $281,016 | |
| 6 | AMGN |
Amgen Inc
|
682 | $246,965 | |
| 7 | MRK |
Merck & Co., Inc.
|
1,710 | $219,735 |
All Filings in GILD
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $370,807 | 2,935 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $401,803 | 2,883 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $356,682 | 2,906 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $323,454 | 2,914 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $329,173 | 2,969 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $660,086 | 5,891 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $543,505 | 5,884 | Shares | Sole | 2025-01-21 | |
| 2024-09-30 | $403,941 | 4,818 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $294,611 | 4,294 | Shares | Sole | 2024-07-26 | |
| 2024-03-31 | $283,257 | 3,867 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $218,808 | 2,701 | Shares | Sole | 2024-02-15 | |
| No filing history on record for this holder in this stock. | ||||||